• Christoph Schwarz, Daniel A Klaus, Bianca Tudor, Edith Fleischmann, Thomas Wekerle, Georg Roth, Martin Bodingbauer, and Klaus Kaczirek.
• Dept. of Surgery, Div. of General Surgery, Medical University of Vienna, Vienna, Austria; Section of Transplantation Immunology, Dept. of Surgery, Medical University of Vienna, Vienna, Austria.
• Plos One. 2015 Jan 1; 10 (10): e0140314.

BackgroundParenchymal transection represents a crucial step during liver surgery and many different techniques have been described so far. Stapler resection is supposed to be faster than CUSA resection. However, whether speed impacts on the inflammatory response in patients undergoing liver resection (LR) remains unclear.Materials And MethodsThis is a randomized controlled trial including 40 patients undergoing anatomical LR. Primary endpoint was transection speed (cm2/min). Secondary endpoints included the perioperative change of pro- and anti-inflammatory cytokines, overall surgery duration, length of hospital stay, morbidity and mortality.ResultsMean transection speed was significantly higher in patients undergoing stapler hepatectomy compared to CUSA resection (CUSA: 1 (0.4) cm2/min vs. Stapler: 10.8 (6.1) cm2/min; p<0.0001). Analyzing the impact of surgery duration on inflammatory response revealed a significant correlation between IL-6 levels measured at the end of surgery and the overall length of surgery (p<0.0001, r = 0.6188). Patients undergoing CUSA LR had significantly higher increase of interleukin-6 (IL-6) after parenchymal transection compared to patients with stapler hepatectomy in the portal and hepatic veins, respectively (p = 0.028; p = 0.044). C-reactive protein levels on the first post-operative day were significantly lower in the stapler cohort (p = 0.010). There was a trend towards a reduced overall surgery time in patients with stapler LR, especially in the subgroup of patients undergoing minor hepatectomies (p = 0.020).ConclusionsLiver resection using staplers is fast, safe and suggests a diminished inflammatory response probably due to a decreased parenchymal transection time.Trial RegistrationClinicalTrials.gov NCT01785212.

27 keywords...

hide…